Description
Unit Size: Each
Extended Spectrum β Lactamases are enzymes capable of conferring bacterial resistance to penicillins, cephalosporins, and aztreonam by hydrolysis of these antibiotics ^1,2. Production of ESBLs is a significant resistance-mechanism that impedes the antimicrobial treatment of infections caused by Enterobacteriaceae and is a serious threat to the currently available antibiotic armory^3.The medium can facilitate earlier identification of colonized patients and can help reduce the cost of surveillance screening.
• Selective: selective agents vancomycin, amphotericin B, ceftazidime, and clindamycin inhibit many commensal organisms found in the large intestine while at the same time allowing the growth of certain resistant organisms.
• Facilitates earlier identification of colonized patients and can help reduce the cost of surveillance screening.
• Ready to use convenience of prepared media.In a study conducted from 2000 to 2005, there were 17,872 inpatients screened for rectal colonization with ESBL-producing Enterobacteriaceae. The colonization rate doubled during this study^4.During the same study cited above, 8.5% of colonized patients developed a subsequent bloodstream infection^4. Surveillance screening is useful for infection control and antimicrobial stewardship in controlling the proliferation of ESBL-producing bacteria. The use of VACC Agar can facilitate earlier identification of colonized patients and can help reduce the cost of surveillance screening. Not all products are available for sale in all territories. Please inquire.Remel™ and Oxoid™ products are now part of the Thermo Scientific brand